Rare diseases
Investigational molecules
Locations
Ul. Augustyna Szamarzewskiego 84, 60-569 Poznan, Poland
The Polish Myeloma Consortium supports clinical research in multiple myeloma with a focus on treatment strategies for patients with biochemical relapse and newly diagnosed disease. Its research activity includes evaluation of anti-CD38 therapy and combination regimens used in disease control.
Clinical interest extends to outcomes linked with disease progression, response maintenance, and prevention of symptomatic relapse in plasma cell dyscrasias.
Polish Myeloma Consortium runs clinical trials in conditions such as Plasma cell myeloma, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
PolandPoland
FinlandPolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
